News Releases
All Releases
View Summary Peregrine Pharmaceuticals Announces the Initiation of Human Antibody Generation Against Two Additional Antigen Targets With Xenerex Biosciences
Dec 20, 2001
PDF 9.4 KB Add to Briefcase
View Summary Peregrine Announces Quarterly Conference Call
Dec 17, 2001
PDF 6.9 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Similar Characteristics of Chimeric and Human TNT Monoclonal Antibodies
Dec 17, 2001
PDF 9.1 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces It has Agreed Upon the Design of a Phase III Study for Brain Cancer With the FDA; Study Will Treat Patients With Recurrent Glioblastoma Multiforme
Dec 13, 2001
PDF 9.3 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces $5.75 Million Investment From Institutional Investors; Company Director Invests in Offering
Nov 19, 2001
PDF 8.6 KB Add to Briefcase
View Summary Peregrine Announces Image Fusion Data From Phase II Cotara Trial; Data To Be Presented at the Meeting of the World Federation of Neuro-Oncology
Nov 16, 2001
PDF 9.1 KB Add to Briefcase
Showing 621-626 of 626 Page: 1 ... 28 29 30 31 32  Previous 20
Add to Briefcase = add release to Briefcase
Print E-mail